Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: axial who wrote (8239)	12/15/2001 8:28:50 PM
From: Montana Wildhack	Respond to of 14101

Hi Jim, You're most welcome to butt in any time so to speak. It's in between periods on the french station. Cash is not an issue because DMX has extended the Aqua deal to May and these draws will come periodically as the labelling issues are decided. There is a well documented cost to the current shareprice which would become quite irrelevant on an FDA/J&J announcement. This is why Rebecca said she estimated cash positive in February. That relates I believe to her estimate of timing to the J&J deal. I would be suprised to be receiving sufficent cash from operations by June/August since I believe it will take longer to realize that. Only the UK will be along the road at 1 1/4 years by then. My best guess is September US launch with the J&J deal announced and the first cash transfered in the March/April timeframe from J&J. By then I suspect we will have launched in Canada but there again I see at least a year to become profitable. On the OXO I suspect some 2/3 of the J&J money is earmarked here with the rest preparing for WF10 approval etc. In my opinion much of the OXO buyout will come from a NASDAQ placement later in 2002 and in a time delayed way from the revenue stream subject to WF10 approval. I would watch for the next placement in February. Wolf